TBC1D4 Activators

The TBC1D4 activator class primarily consists of chemicals that modulate insulin signaling or related pathways, thereby influencing the function of TBC1D4 indirectly. Among these, Metformin and AICAR are renowned for their AMPK activating capabilities. AMPK activation can promote the translocation of GLUT4 to the cell surface, a process in which TBC1D4 plays a crucial role. Similarly, Resveratrol and Berberine are known to activate AMPK, highlighting the significance of AMPK in this context.

Another group within this class are PPARγ agonists, such as Rosiglitazone and Pioglitazone. Activation of PPARγ can enhance insulin sensitivity, potentially influencing the TBC1D4 activity in glucose uptake. D-chiro-inositol is also noted for its ability to enhance insulin signaling. Furthermore, chemicals like Exendin-4 and Liraglutide, which are GLP-1 receptor agonists, can augment insulin secretion and action. This influence on insulin signaling can also indirectly affect TBC1D4. Lastly, Dapagliflozin, Tofogliflozin, and Sitagliptin, which are SGLT2 inhibitors and DPP-4 inhibitors, respectively, have the capability to improve glycemic control, leading to an environment where TBC1D4 can be indirectly affected due to modulations in glucose and insulin dynamics.